Pathophysiologic effects of a toxic peptide from Microcystis aeruginosa

Insights

Hepatocellular damage from CCl4 protects mice from acute Toxin-LR death. However, hydrocortisone prevents both acute and delayed deaths, suggesting a role beyond direct liver toxicity for this cyanotoxin.

Area of Science:

  • Toxicology
  • Pharmacology
  • Hepatology

Background:

  • Microcystis aeruginosa produces Toxin-LR, a hexapeptide known for acute toxicity.
  • Toxin-LR causes hepatic vascular congestion, thrombocytopenia, and pulmonary thrombi, leading to rapid death in mice.
  • Its classification as solely an hepatotoxin is questioned by observed protective mechanisms.

Purpose of the Study:

  • To investigate the protective effects of prior hepatocellular damage on Toxin-LR lethality.
  • To explore the role of microsomal enzymes and hydrocortisone in Toxin-LR toxicity.
  • To determine if Toxin-LR directly affects platelet aggregation or induces a humoral factor.

Main Methods:

  • Mice were pretreated with carbon tetrachloride (CCl4) to induce hepatocellular damage before Toxin-LR administration.
  • Mice were pretreated with microsomal enzyme inhibitors (SKF 525A, cobaltous chloride) and hydrocortisone.
  • Effects of X-irradiation-induced thrombocytopenia on lethality were assessed.
  • In vitro platelet aggregation and detection of humoral factors in plasma were performed.

Main Results:

  • Sublethal CCl4 pretreatment prevented acute Toxin-LR deaths, but delayed mortality increased.
  • Microsomal enzyme inhibitors did not alter acute lethality.
  • Pharmacologic doses of hydrocortisone prevented both acute and delayed deaths.
  • Thrombocytopenia or leukopenia did not significantly affect Toxin-LR lethality.
  • No in vitro platelet aggregation or lysis was observed; no humoral aggregating factor was detected.

Conclusions:

  • Hepatocellular damage can mitigate acute Toxin-LR lethality, indicating a complex toxic mechanism.
  • Hydrocortisone demonstrates significant protective effects against both acute and delayed Toxin-LR toxicity.
  • Toxin-LR's lethality is not solely dependent on direct platelet effects or induced humoral factors.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...